Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Stage

Acquired Unit | Acquired

Valuation

$0000 

About Allergan - U.S. Dermatology Portfolio

Allergan (NYSE: AGN), fka Actavis and before that Watson Pharmaceuticals, is a global pharmaceutical company focused on developing, manufacturing, and commercializing innovative branded pharmaceuticals, high-quality generic, and over-the-counter medicines and biologic products for patients around the world. Allergan markets a portfolio of products that provide treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular, and anti-infective therapeutic categories. Actavis is also engaged in research and development. Watson Pharmaceuticals took on the name Actavis after its 2012 acquisition of the Swiss drug maker of the same name; Actavis later took on the name Allergan after its 2015 acquisition of the American health care company of the same name.

Allergan - U.S. Dermatology Portfolio Headquarter Location

Clonshaugh Business and Technology Park Coolock

Dublin, D17 E400,

Ireland

862-261-7000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.